{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:31:53Z","timestamp":1740137513991,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["N01\u2010HC\u201025195","HHSN268201500001","R01-HL134168","R01-HL131532","R01-HL143227","R01-HL142983","K23-HL153888"],"award-info":[{"award-number":["N01\u2010HC\u201025195","HHSN268201500001","R01-HL134168","R01-HL131532","R01-HL143227","R01-HL142983","K23-HL153888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2020059"],"award-info":[{"award-number":["2020059"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Ultrasound"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Immune-inflammatory myocardial disease contributes to multiple chronic cardiac processes, but access to non-invasive screening is limited. We have previously developed a method of echocardiographic texture analysis, called the high-spectrum signal intensity coefficient (HS-SIC) which assesses myocardial microstructure and previously associated with myocardial fibrosis. We aimed to determine whether this echocardiographic texture analysis of cardiac microstructure can identify inflammatory cardiac disease in the clinical setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective case-control study of 318 patients with distinct clinical myocardial pathologies and 20 healthy controls. Populations included myocarditis, atypical chest pain\/palpitations, STEMI, severe aortic stenosis, acute COVID infection, amyloidosis, and cardiac transplantation with acute rejection, without current rejection but with prior rejection, and with no history of rejection. We assessed the HS-SIC\u2019s ability to differentiate between a broader diversity of clinical groups and healthy controls. We used Kruskal-Wallis tests to compare HS-SIC values measured in each of the clinical populations with those in the healthy control group and compared HS-SIC values between the subgroups of cardiac transplantation rejection status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>For the total sample of <jats:italic>N<\/jats:italic>\u00a0=\u2009338, the mean age was 49.6\u2009\u00b1\u200920.9\u2009years and 50% were women. The mean\u2009\u00b1\u2009standard error of the mean of HS-SIC were: 0.668\u2009\u00b1\u20090.074 for controls, 0.552\u2009\u00b1\u20090.049 for atypical chest pain\/palpitations, 0.425\u2009\u00b1\u20090.058 for myocarditis, 0.881\u2009\u00b1\u20090.129 for STEMI, 1.116\u2009\u00b1\u20090.196 for severe aortic stenosis, 0.904\u2009\u00b1\u20090.116 for acute COVID, and 0.698\u2009\u00b1\u20090.103 for amyloidosis. Among cardiac transplant recipients, HS-SIC values were 0.478\u2009\u00b1\u20090.999 for active rejection, 0.594\u2009\u00b1\u20090.091 for prior rejection, and 1.191\u2009\u00b1\u20090.442 for never rejection. We observed significant differences in HS-SIC between controls and myocarditis (<jats:italic>P<\/jats:italic>\u00a0=\u20090.0014), active rejection (<jats:italic>P<\/jats:italic>\u00a0=\u20090.0076), and atypical chest pain or palpitations (<jats:italic>P<\/jats:italic>\u00a0=\u20090.0014); as well as between transplant patients with active rejection and those without current or prior rejection (<jats:italic>P<\/jats:italic>\u00a0=\u20090.031).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>An echocardiographic method can be used to characterize tissue signatures of microstructural changes across a spectrum of cardiac disease including immune-inflammatory conditions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12947-022-00279-0","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:02:22Z","timestamp":1649034142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac microstructural alterations in immune-inflammatory myocardial disease: a retrospective case-control study"],"prefix":"10.1186","volume":"20","author":[{"given":"Alan C.","family":"Kwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerran","family":"Salto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor-Trung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Luong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranoti","family":"Hiremath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Ebinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon A.","family":"Kobashigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jignesh K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4977-036X","authenticated-orcid":false,"given":"Susan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"issue":"1","key":"279_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1161\/CIRCRESAHA.111.243170","volume":"110","author":"DJ Marchant","year":"2012","unstructured":"Marchant DJ, Boyd JH, Lin DC, Granville DJ, Garmaroudi FS, McManus BM. Inflammation in myocardial diseases. Circ Res. 2012;110(1):126\u201344.","journal-title":"Circ Res"},{"issue":"2","key":"279_CR2","doi-asserted-by":"publisher","first-page":"456S","DOI":"10.1093\/ajcn\/83.2.456S","volume":"83","author":"P Libby","year":"2006","unstructured":"Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83(2):456S\u201360S.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"279_CR3","doi-asserted-by":"publisher","first-page":"e97424","DOI":"10.1371\/journal.pone.0097424","volume":"9","author":"P Hiremath","year":"2014","unstructured":"Hiremath P, Bauer M, Aguirre AD, et al. Identifying early changes in myocardial microstructure in hypertensive heart disease. PLoS One. 2014;9(5):e97424.","journal-title":"PLoS One"},{"issue":"83","key":"279_CR4","first-page":"e50850","volume":"14","author":"P Hiremath","year":"2014","unstructured":"Hiremath P, Bauer M, Cheng HW, Unno K, Liao R, Cheng S. Ultrasonic assessment of myocardial microstructure. J Vis Exp. 2014;14(83):e50850.","journal-title":"J Vis Exp"},{"key":"279_CR5","doi-asserted-by":"crossref","unstructured":"Hiremath P, Lawler PR, Ho JE, et al. Ultrasonic assessment of myocardial microstructure in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circulation Heart Failure. 2016;9(9):e003026.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003026"},{"issue":"11","key":"279_CR6","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/aje\/kwm021","volume":"165","author":"GL Splansky","year":"2007","unstructured":"Splansky GL, Corey D, Yang Q, et al. The third generation cohort of the National Heart, Lung, and Blood Institute's Framingham heart study: design, recruitment, and initial examination. Am J Epidemiol. 2007;165(11):1328\u201335.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"279_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ehjci\/jeaa028","volume":"21","author":"Z Raisi-Estabragh","year":"2020","unstructured":"Raisi-Estabragh Z, Izquierdo C, Campello VM, et al. Cardiac magnetic resonance radiomics: basic principles and clinical perspectives. Europ Heart J Cardiovasc Imaging. 2020;21(4):349\u201356.","journal-title":"Europ Heart J Cardiovasc Imaging"},{"issue":"9","key":"279_CR8","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/oby.21936","volume":"25","author":"JE Ho","year":"2017","unstructured":"Ho JE, Rahban Y, Sandhu H, et al. Preclinical alterations in myocardial microstructure in people with metabolic syndrome. Obesity (Silver Spring). 2017;25(9):1516\u201322.","journal-title":"Obesity (Silver Spring)"},{"key":"279_CR9","doi-asserted-by":"publisher","unstructured":"Duffy G, Cheng PP, Yuan N, et al. High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning. JAMA Cardiol. Published online February 23, 2022. https:\/\/doi.org\/10.1001\/jamacardio.2021.6059.","DOI":"10.1001\/jamacardio.2021.6059"}],"container-title":["Cardiovascular Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12947-022-00279-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12947-022-00279-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12947-022-00279-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:02:34Z","timestamp":1649034154000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiovascularultrasound.biomedcentral.com\/articles\/10.1186\/s12947-022-00279-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1186\/s12947-022-00279-0","relation":{},"ISSN":["1476-7120"],"issn-type":[{"type":"electronic","value":"1476-7120"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols were approved by our institutional review boards; written informed consent was obtained from all participants of the screening cohort, and informed consent was waived for retrospective data analyses for the clinical cohort.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The echocardiography image in Fig.  is from an anonymized participant of the Framingham Offspring Study with any identifying information removed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}